Print PDF

Sheppard Mullin Advised Avego Management in $22 Million Financing in PBS Biotech


Sheppard Mullin represented Avego Management (Avego), a healthcare-focused investment firm, as lead investor in a $22,000,000 financing round for PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider. PBS Biotech received additional financing from existing investor BroadOak Capital Partners. The financing will be used to improve the company's products portfolio, expand its process development services capability, and increase customer support for global cell therapy clients.

The Sheppard Mullin deal team that advised Avego was led by Farha Moiduddin and Shon Glusky. Invaluable assistance was provided by Jonathan Barker, Dmitriy Chelnitsky, Theo Mayer, Zana Operta, Andrea Ramos, Jennifer Redmond, Joey Tongson, Daniel Yannuzzi, Carol Archer, Leo Caseria, Frank Dworak, Keith Gercken, Deena Muzafar, Kaley Rush and Jason Schendel.

Click here to read the press release.


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.